[{"address1": "910 Clopper Road", "address2": "Suite 201S", "city": "Gaithersburg", "state": "MD", "zip": "20878", "country": "United States", "phone": "240 654 1450", "website": "https://altimmune.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity, metabolic, and liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 trial for the treatment of obesity and metabolic associated steatohepatitis. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.", "fullTimeEmployees": 59, "companyOfficers": [{"maxAge": 1, "name": "Dr. Vipin K. Garg Ph.D.", "age": 66, "title": "President, CEO & Director", "yearBorn": 1958, "fiscalYear": 2024, "totalPay": 992999, "exercisedValue": 0, "unexercisedValue": 1959778}, {"maxAge": 1, "name": "Dr. M. Scot Roberts Ph.D.", "age": 65, "title": "Chief Scientific Officer", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 648960, "exercisedValue": 0, "unexercisedValue": 290514}, {"maxAge": 1, "name": "Mr. Gregory L. Weaver CPA, M.B.A.", "age": 68, "title": "Chief Financial Officer", "yearBorn": 1956, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew  Shutterly M.S.", "age": 36, "title": "Principal Financial & Accounting Officer and Corporate Controller", "yearBorn": 1988, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bertrand  Georges Ph.D.", "title": "Chief Technology Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Tony  Blandin B.S.", "title": "Vice President of Quality & Compliance Management", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Robin E. Abrams J.D.", "age": 60, "title": "General Counsel & Chief Legal Officer", "yearBorn": 1964, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Raymond M. Jordt M.B.A.", "age": 51, "title": "Chief Business Officer", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 578850, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Linda M. Richardson", "age": 60, "title": "Chief Commercial Officer", "yearBorn": 1964, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Christophe  Arbet-Engels M.B.A., M.D., Ph.D.", "age": 62, "title": "Chief Medical Officer", "yearBorn": 1962, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 6, "compensationRisk": 9, "shareHolderRightsRisk": 4, "overallRisk": 6, "governanceEpochDate": 1764547200, "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://ir.pharmathene.com/phoenix.zhtml?c=191999&p=irol-irhome", "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 5.34, "open": 5.395, "dayLow": 5.25, "dayHigh": 6.0299, "regularMarketPreviousClose": 5.34, "regularMarketOpen": 5.395, "regularMarketDayLow": 5.25, "regularMarketDayHigh": 6.0299, "exDividendDate": 1484870400, "payoutRatio": 0.0, "beta": -0.036, "forwardPE": -4.005442, "volume": 6360846, "regularMarketVolume": 6360846, "averageVolume": 3070519, "averageVolume10days": 3429500, "averageDailyVolume10Day": 3429500, "bid": 5.18, "ask": 5.43, "bidSize": 32, "askSize": 32, "marketCap": 549884352, "fiftyTwoWeekLow": 2.9, "fiftyTwoWeekHigh": 9.59, "allTimeHigh": 137.7, "allTimeLow": 1.51, "priceToSalesTrailing12Months": 27494.217, "fiftyDayAverage": 4.3728, "twoHundredDayAverage": 4.6841, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 354548480, "profitMargins": 0.0, "floatShares": 103561925, "sharesOutstanding": 104342385, "sharesShort": 23157756, "sharesShortPriorMonth": 21780366, "sharesShortPreviousMonthDate": 1761868800, "dateShortInterest": 1764288000, "sharesPercentSharesOut": 0.2219, "heldPercentInsiders": 0.00672, "heldPercentInstitutions": 0.40417, "shortRatio": 7.26, "shortPercentOfFloat": 0.2233, "impliedSharesOutstanding": 104342385, "bookValue": 1.941, "priceToBook": 2.7150953, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -83915000, "trailingEps": -1.07, "forwardEps": -1.31571, "lastSplitFactor": "1:30", "lastSplitDate": 1536883200, "enterpriseToRevenue": 17727.426, "enterpriseToEbitda": -3.924, "52WeekChange": -0.4066667, "SandP52WeekChange": 0.13613915, "quoteType": "EQUITY", "currentPrice": 5.27, "targetHighPrice": 28.0, "targetLowPrice": 1.0, "targetMeanPrice": 17.875, "targetMedianPrice": 19.0, "recommendationMean": 1.88889, "recommendationKey": "buy", "numberOfAnalystOpinions": 8, "totalCash": 210776000, "totalCashPerShare": 2.022, "ebitda": -90343000, "totalDebt": 15905000, "quickRatio": 16.831, "currentRatio": 17.183, "totalRevenue": 20000, "debtToEquity": 8.569, "revenuePerShare": 0.0, "returnOnAssets": -0.30868998, "returnOnEquity": -0.52615, "grossProfits": -67784000, "freeCashflow": -37671376, "operatingCashflow": -66352000, "revenueGrowth": 0.0, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -4171.8, "financialCurrency": "USD", "symbol": "ALT", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Altimmune, Inc.", "longName": "Altimmune, Inc.", "regularMarketChangePercent": -1.31086, "regularMarketPrice": 5.27, "corporateActions": [], "postMarketTime": 1765587593, "regularMarketTime": 1765573202, "exchange": "NGM", "messageBoardId": "finmb_4866807", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "dividendDate": 1536883200, "earningsTimestamp": 1762435800, "earningsTimestampStart": 1762435800, "earningsTimestampEnd": 1762435800, "earningsCallTimestampStart": 1762435800, "earningsCallTimestampEnd": 1762435800, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -1.07, "epsForward": -1.31571, "epsCurrentYear": -0.98714, "priceEpsCurrentYear": -5.338655, "fiftyDayAverageChange": 0.8972001, "fiftyDayAverageChangePercent": 0.20517749, "twoHundredDayAverageChange": 0.58589983, "twoHundredDayAverageChangePercent": 0.12508269, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.9 - Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1495805400000, "postMarketChangePercent": 0.9487702, "postMarketPrice": 5.32, "postMarketChange": 0.05000019, "regularMarketChange": -0.0700002, "regularMarketDayRange": "5.25 - 6.0299", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 3070519, "fiftyTwoWeekLowChange": 2.37, "fiftyTwoWeekLowChangePercent": 0.8172413, "fiftyTwoWeekRange": "2.9 - 9.59", "fiftyTwoWeekHighChange": -4.32, "fiftyTwoWeekHighChangePercent": -0.45046926, "fiftyTwoWeekChangePercent": -40.666668, "marketState": "CLOSED", "displayName": "Altimmune", "trailingPegRatio": null, "__fetch_time": "2025-12-13"}]